← FDA Drug Approvals (Drugs@FDA)
LAMIVUDINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PHARMOBEDIENT · Approved 2019-03-05
Drug application
- FDA Application #
ANDA078545- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LAMIVUDINE
- Generic name
- Lamivudine
- Active ingredients
- LAMIVUDINE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- PHARMOBEDIENT
- First approval
- 2019-03-05
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown